A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Jan, 13 2026
Nov, 26 2025
Sep, 23 2025
Aug, 6 2026
Jan, 28 2025